Nebulizers, which utilize water or saline to deliver medicines directly to the lungs in a harmless vapor without heat or combustion, have been approved for decades as a safe, effective method to ...
More than 16 million Americans have been diagnosed with chronic obstructive pulmonary disease (COPD) — a group of conditions that cause breathing-related problems. In 2017, 923,000 patients went to ...
BUFORD, Ga. , Jan. 25, 2023 (GLOBE NEWSWIRE) -- Synergy Life Science, Inc. (“Synergy”), a company pioneering the development of novel ingredients and innovative products for the consumer health and ...
The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...
(StatePoint) If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you receive can impact your health outcomes and quality of life. That ...
Successful device feasibility study with sterna biological's asthma drug candidate SB010 enable selection of optimal nebulizers for late-stage development and commercialization The issuer is solely ...
BURLINGAME, Calif., Jan. 16, 2024 /PRNewswire/ -- CoherentMI published a report, titled, Global Ultrasonic Nebulizer Market Size is estimated to grow from US$ 218.3 Million in 2023 and is forecast to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results